Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia‐mediated ERK1/2–NF‐κB signaling pathway-Reference-Cited by-同舟云学术

Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia‐mediated ERK1/2–NF‐κB signaling pathway

Published:2019-07-31 Issue:11 Volume:33 Page:11776-11790
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhang Tianyu¹,Ouyang Hao¹,Mei Xiyu¹,Lu Bin¹,Yu Zengyang¹,Chen Kaixian¹,Wang Zhengtao¹,Ji Lili¹

Affiliation:

1. The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese MedicinesShanghai Key Laboratory of Compound Chinese Medicines‐The State Administration of Traditional Chinese Medicine (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese MedicinesInstitute of Chinese Materia MedicaShanghai University of Traditional Chinese MedicineShanghaiChina

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802614RRR

Reference53 articles.

1. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2018

2. Improvements in life expectancy in type 1 diabetes patients in the last six decades

3. Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease Duration